HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].

Abstract
Multiple-drug (OK-432, PSK and SPG) immunotherapy and chemotherapy provided remission of symptoms for 36 months in a patient aged 21 years suffering scirrhous gastric carcinoma associated with carcinomatous peritonitis in which direct infiltration to the pancreas, retroperitoneum and the left colon was observed. A remarkable improvement with time was observed by endoscopic and roentgenographic observation, and a substantial improvement was also observed in the NK-cell ratios of lymphocyte subsets of the OKT series in relation to immunologic parameters. A tumor necrosis factor [TNF]-like substance was thought to have been induced by multiimmunotherapy in this case.
AuthorsA Yagita, I Orima, N Okada, S Ootsuka, T Oda, N Takeuchi, N Hosaka, H Matsumoto, H Itoh, M Ono
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 14 Issue 1 Pg. 196-9 (Jan 1987) ISSN: 0385-0684 [Print] Japan
PMID3026254 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biological Products
  • Glycosaminoglycans
  • Mitomycins
  • Proteoglycans
  • Carbazilquinone
  • Picibanil
  • polysaccharide-K
  • Mitomycin
  • Sizofiran
Topics
  • Adenocarcinoma, Scirrhous (drug therapy)
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Biological Products (administration & dosage)
  • Carbazilquinone (administration & dosage)
  • Glycosaminoglycans (administration & dosage)
  • Humans
  • Male
  • Mitomycin
  • Mitomycins (administration & dosage)
  • Picibanil (administration & dosage)
  • Proteoglycans (administration & dosage)
  • Sizofiran (administration & dosage)
  • Stomach Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: